FDA Grants Emergency Approval To Pfizer-BioNTech COVID-19 Vaccine

FDA Grants Emergency Approval To Pfizer-BioNTech COVID-19 Vaccine

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

Pfizer's COVID-19 vaccine, the first to receive emergency approval in the US, uses mRNA technology to trigger an immune response. It requires two doses, 21 days apart, and is 95% effective. Distribution involves logistical challenges, including repurposing and unfrozen vaccines, and managing healthcare workers' schedules to avoid crowding and handle potential side effects. Hospitals are preparing to receive and administer vaccines, with plans to start vaccinations shortly after arrival.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What technology does Pfizer's COVID-19 vaccine use to generate an immune response?

Protein subunit

Viral vector

Messenger RNA

DNA technology

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main logistical challenge mentioned in distributing the vaccine?

Manufacturing delays

Lack of transportation

Organizing vaccination schedules

Storage temperature requirements

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is it important to time the vaccinations properly for healthcare workers?

To increase the vaccine's effectiveness

To reduce the cost of vaccination

To prevent a whole unit from being out due to side effects

To ensure all workers are vaccinated at once

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What are some potential side effects of the Pfizer COVID-19 vaccine?

Nausea and vomiting

Aches and fatigue

Rash and itching

Dizziness and headache

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

When do hospitals plan to start vaccinating healthcare workers after receiving the doses?

Wednesday or Thursday

Immediately upon arrival

The following weekend

After a month